Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Leaky Scanning02:28

Leaky Scanning

5.6K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Invasive Fungal Sinusitis in Patients With Hematological Malignancies: A 20-Year Study From a Tertiary Academic US Hospital System.

Open forum infectious diseases·2026
Same author

Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical Response.

Open forum infectious diseases·2026
Same author

Safety and immunogenicity of PanChol, a single-dose live-attenuated oral cholera vaccine: results from a phase 1a, double-blind, randomised, placebo-controlled trial.

The Lancet. Infectious diseases·2026
Same author

Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.

Vaccine·2025
Same author

Acute SARS-CoV-2 infection.

Nature reviews. Disease primers·2025
Same author

Editorial for the special issue "Vaccines for the vulnerable".

Vaccine·2025
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

26.0K

Update on Influenza.

Alisse Hannaford1, Muneerah Aleissa2, Amy C Sherman1

  • 1Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

The American Journal of the Medical Sciences
|October 24, 2025
PubMed
Summary
This summary is machine-generated.

Influenza poses a global health threat. This review synthesizes current and emerging strategies for influenza diagnostics, therapeutics, and vaccines to improve public health outcomes in the United States.

Keywords:
Infectious diseaseInfluenzaPharmacology

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.5K
Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.7K

Related Experiment Videos

Last Updated: Jan 14, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

26.0K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.5K
Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.7K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Influenza presents ongoing global health challenges due to evolving clinical and epidemiological characteristics, causing significant morbidity and mortality.
  • Vaccine development, including annual strain selection and advanced formulations, is crucial for influenza prevention.
  • Emerging threats necessitate continuous innovation in diagnostics, therapeutics, and preventative measures.

Purpose of the Study:

  • To provide a comprehensive review of current knowledge and emerging strategies for influenza control.
  • To synthesize information on diagnostics, therapeutics, and prevention of influenza.
  • To inform strategies for strengthening clinical outcomes and public health responses to influenza in the United States.

Main Methods:

  • Literature review of current research and emerging technologies in influenza.
  • Synthesis of data on vaccine development, including novel platforms and administration routes.
  • Evaluation of antiviral roles, resistance trends, and considerations for vulnerable populations.

Main Results:

  • Influenza vaccine development is advancing with enhanced formulations and new technologies like mRNA.
  • Next-generation, multi-pathogen, and universal influenza vaccines are under development.
  • Antivirals play a key role in prophylaxis and treatment, with ongoing monitoring for resistance.

Conclusions:

  • A multi-faceted approach combining advanced diagnostics, effective therapeutics, and innovative vaccines is essential for managing influenza.
  • Continuous research and development are critical to address the evolving nature of influenza viruses.
  • Strengthening public health responses requires integrating the latest scientific advancements in influenza prevention and control.